Beyond COVID-19 Spending Growth, Biosimilars Slowed Growth In Other Categories

IQVIA Finds Non-COVID Drug Spending Up Just 5%

 
• By Alaric DeArment
A shot directly from above of a cut dollar sign on the right with various pills arranged on the top of it on the green background - Image
IQVIA's Institute for Human Data Science released its drug spending report for 2022 • Source: Shutterstock

More from COVID-19

More from Scrip